- Home
- OSRH vs ADVB Comparison
OSRH vs ADVB Comparison
Compare OSRH & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- ADVB
- Stock Information
- Founded
- OSRH N/A
- ADVB 2014
- Country
- OSRH United States
- ADVB United States
- Employees
- OSRH N/A
- ADVB N/A
- Industry
- OSRH
- ADVB Medical Specialities
- Sector
- OSRH
- ADVB Health Care
- Exchange
- OSRH Nasdaq
- ADVB Nasdaq
- Market Cap
- OSRH 13.2M
- ADVB 12.2M
- IPO Year
- OSRH N/A
- ADVB 2025
- Fundamental
- Price
- OSRH $0.71
- ADVB $0.44
- Analyst Decision
- OSRH
- ADVB
- Analyst Count
- OSRH 0
- ADVB 0
- Target Price
- OSRH N/A
- ADVB N/A
- AVG Volume (30 Days)
- OSRH 2.0M
- ADVB 943.8K
- Earning Date
- OSRH 11-24-2025
- ADVB 10-27-2025
- Dividend Yield
- OSRH N/A
- ADVB N/A
- EPS Growth
- OSRH N/A
- ADVB N/A
- EPS
- OSRH N/A
- ADVB N/A
- Revenue
- OSRH $104,735.00
- ADVB N/A
- Revenue This Year
- OSRH N/A
- ADVB N/A
- Revenue Next Year
- OSRH N/A
- ADVB N/A
- P/E Ratio
- OSRH N/A
- ADVB N/A
- Revenue Growth
- OSRH N/A
- ADVB N/A
- 52 Week Low
- OSRH $0.45
- ADVB $0.34
- 52 Week High
- OSRH $13.40
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- OSRH 55.77
- ADVB 47.46
- Support Level
- OSRH $0.59
- ADVB $0.43
- Resistance Level
- OSRH $0.82
- ADVB $0.62
- Average True Range (ATR)
- OSRH 0.11
- ADVB 0.06
- MACD
- OSRH 0.02
- ADVB 0.00
- Stochastic Oscillator
- OSRH 51.20
- ADVB 22.10
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.